Short answer
SHOULDER INNOVATIONS, INC. (SI) filed an 8-K current report with the SEC on March 2, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Geoff Pardo resigned Feb 26, 2026 from Board, Compensation Committee, and Chair of Nominating & Corporate Governance Committee: no disagreement cited.
SHOULDER INNOVATIONS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Geoff Pardo resigned Feb 26, 2026 from Board, Compensation Committee, and Chair of Nominating & Corporate Governance Committee: no disagreement cited
- Andrew Hykes (age 53) appointed Class I director and Compensation Committee member, filling Pardo's vacancy effective immediately
- Hykes brings deep medtech operational experience: CEO/President of Inari Medical (2023–2025) and prior COO/CCO roles there; now CEO of Okami Medical since Oct 2025
- Earlier career includes VP roles at Medtronic and neurovascular startup Sequent Medical (acquired by Terumo 2016): strong commercial and regulatory background
- Hykes deemed independent by Board, compensated under existing Non-Employee Director Compensation Program; no related-party transaction concerns flagged
Item 7.01 · Regulation FD Disclosure
- Press release issued March 2, 2026 disclosing material company developments: full details in Exhibit 99.1
- Reg FD filing ensures simultaneous public disclosure, signaling information deemed market-moving by management
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SHOULDER INNOVATIONS, INC. 8-K filings
Get the next SI 8-K as it lands
Follow SI for push alerts, or ask the research agent what this filing means.